Skip to content

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at UVa

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at University of Virginia (UVa)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05857488
Enrollment
1
Registered
2023-05-12
Start date
2022-01-01
Completion date
2022-06-17
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

OCT

Brief summary

The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.

Detailed description

A total of fifteen (15) subjects, infants 6 months of age to 48 months of age will be enrolled in this study. While the subject is awake and unseated, a catheter with optical coherence tomography (OCT) imaging technology will be introduced transnasally. Images will be acquired while the tube is moved through the subject's GI tract. After imaging is complete, accessory device(s) may be threaded through the catheter to collect samples of the gut microbiome and/or measure intestinal potential difference.

Interventions

DEVICETransnasal introduction tube

Imaging of the GI tract using the transnasal introduction tube and system. Optional gut microbiome sample collection using the microbiome brush and/or intestinal potential difference measurement using the intestinal potential difference probe.

Sponsors

Bill and Melinda Gates Foundation
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 48 Months
Healthy volunteers
Yes

Inclusion criteria

* 6 to 48 month old infants that can follow fasting requirements

Exclusion criteria

* Any infant under 6kg of weight since this is the minimum weight for 6.5 F nasogastric (NG) tube * Any infant whose nasal passage cannot reasonably accommodate a 6.5 French nasoduodenal catheter. * Any infants with absolute or relative contraindications to transnasal tubes: 1. severe midface trauma and recent nasal, throat, or esophageal surgery. 2. Esophageal varices, esophageal stricture, and alkaline ingestion 3. Congenital anatomical defects affecting the gastrointestinal tract, most specifically cleft lip and/or cleft palate. * Any infant with absolute or relative contraindication to a duodenal biopsy: 1. post bone marrow transplant 2. coagulation abnormalities

Design outcomes

Primary

MeasureTime frameDescription
Ability to Acquire Intestinal Images in an Unsedated InfantApproximate 90 minute study visitCan the technology successfully collect images of the small intestine in an unseated infant?
Ability for Unsedated Infant Subjects to Tolerate the DeviceApproximate 90 minute study visitCan the unsedated infant subjects tolerate the administration of the device with minimal discomfort?
Ability to Visualize Features of the Small Intestine in Unsedated Infants.Approximate 90 minute study visitCan the technology successfully visualize features of the small intestine (villi etc) on OCT in unsedated infants?
Ability to Acquire Microbiome Brush and Intestinal Potential Difference SamplesApproximate 90 minute study visitCan the technology successfully collect microbiome brush and/or intestinal potential differences samples?

Secondary

MeasureTime frameDescription
Amount and Composition of Microbial Samples Acquired Via Microbiome Brush Sampling in Unsedated InfantsApproximate 90 minute study visitMeasurements including DNA load and microbial composition will be collected.
Ability to Collect Intestinal Potential Difference Measurements in Various Locations in the Gastrointestinal Tract of Unsedated InfantsApproximate 90 minute study visitIntestinal potential difference measurements will be collected at various locations to determine the feasibility of measuring IPD in unsedated infants

Countries

United States

Participant flow

Participants by arm

ArmCount
Trans Nasal Endomicroscopy Imaging
The subject will have the transnasal introduction tube inserted, and OCT images will be acquired using the OCT compact imaging system. The subject may also undergo a microbiome brushing and/or intestinal potential difference measurement procedure during the study visit. Transnasal introduction tube: Imaging of the GI tract using the transnasal introduction tube and system. Optional gut microbiome sample collection using the microbiome brush and/or intestinal potential difference measurement using the intestinal potential difference probe.
1
Total1

Baseline characteristics

CharacteristicTrans Nasal Endomicroscopy Imaging
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous27 Months
STANDARD_DEVIATION 0
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
1 Participants
Region of Enrollment
United States
1 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1
other
Total, other adverse events
0 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

Ability for Unsedated Infant Subjects to Tolerate the Device

Can the unsedated infant subjects tolerate the administration of the device with minimal discomfort?

Time frame: Approximate 90 minute study visit

Population: The procedure was tolerated by the study participant during insertion, imaging of the stomach and removal of the TNIT but the procedure was terminated early due to loss of imaging signal while in the stomach, with no clinical or safety impact on the study participant. Tolerability could not be assessed for some portions of the study procedure including transit to the small intestine, IPD measurements and microbiome brush sample collection.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Trans Nasal Endomicroscopy ImagingAbility for Unsedated Infant Subjects to Tolerate the Device1 Participants
Primary

Ability to Acquire Intestinal Images in an Unsedated Infant

Can the technology successfully collect images of the small intestine in an unseated infant?

Time frame: Approximate 90 minute study visit

Population: Procedure was terminated early due to loss of the imaging signal, therefore no OCT images of the small intestines were acquired for this subject, thus this participant could not be assessed for this outcome measure.

Primary

Ability to Acquire Microbiome Brush and Intestinal Potential Difference Samples

Can the technology successfully collect microbiome brush and/or intestinal potential differences samples?

Time frame: Approximate 90 minute study visit

Population: The procedure was terminated early and target samples were not collected in the enrolled subject. Subsequently, a shift occurred in the focus of the research, following the emergence of new scientific knowledge regarding the disease. Hence, study was terminated early and withdrawn by the investigator and no further subjects were enrolled.

Primary

Ability to Visualize Features of the Small Intestine in Unsedated Infants.

Can the technology successfully visualize features of the small intestine (villi etc) on OCT in unsedated infants?

Time frame: Approximate 90 minute study visit

Population: OCT images were acquired through the TNIT from the esophagus and stomach but the procedure was terminated early due to loss of imaging signal while in the stomach, with no clinical or safety impact on the study participant. Features of the small intestine (villi etc) could not be assessed.

Secondary

Ability to Collect Intestinal Potential Difference Measurements in Various Locations in the Gastrointestinal Tract of Unsedated Infants

Intestinal potential difference measurements will be collected at various locations to determine the feasibility of measuring IPD in unsedated infants

Time frame: Approximate 90 minute study visit

Population: The procedure was terminated early prior to the TNIT entering the small intestine due to loss of imaging signal while in the stomach, with no clinical or safety impact on the study participant and IPD measurements were not collected.

Secondary

Amount and Composition of Microbial Samples Acquired Via Microbiome Brush Sampling in Unsedated Infants

Measurements including DNA load and microbial composition will be collected.

Time frame: Approximate 90 minute study visit

Population: The procedure was terminated early and target samples were not collected in the enrolled subject. Subsequently, a shift occurred in the focus of the research, following the emergence of new scientific knowledge regarding the disease. Hence, study was terminated early and withdrawn by the investigator and no further subjects were enrolled.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026